MedPath

Micafungin

Generic Name
Micafungin
Brand Names
Mycamine
Drug Type
Small Molecule
Chemical Formula
C56H71N9O23S
CAS Number
235114-32-6
Unique Ingredient Identifier
R10H71BSWG

Overview

Micafungin is an antifungal drug. It belongs to the antifungal class of compounds known as echinocandins and exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall.

Background

Micafungin is an antifungal drug. It belongs to the antifungal class of compounds known as echinocandins and exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall.

Indication

Indicated for the treatment of candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, as well as esophageal candidiasis, and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation. Micafungin is also used as an alternative for the treatment of oropharyngeal candidiases and has been used with some success as primary or salvage therapy, alone or in combination with other antifungals, for the treatment of invasive aspergillosis. Indicated for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.

Associated Conditions

  • Abscesses
  • Aspergillosis
  • Candidemia
  • Candidiasis
  • Esophageal Candidiasis
  • Fungal Infections
  • Fungal peritonitis caused by Candida
  • Acute disseminated Candidiasis

FDA Approved Products

Micafungin
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:50 mg in 1 1
Approved: 2022/09/06
NDC:63323-728
Mycamine
Manufacturer:Astellas Pharma US, Inc.
Route:INTRAVENOUS
Strength:10 mg in 1 mL
Approved: 2020/07/23
NDC:0469-3250
Micafungin in Sodium Chloride
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:50 mg in 50 mL
Approved: 2023/09/29
NDC:0338-9051
Micafungin
Manufacturer:Zydus Pharmaceuticals USA Inc.
Route:INTRAVENOUS
Strength:20 mg in 1 mL
Approved: 2023/06/24
NDC:70710-1725
Micafungin
Manufacturer:Zydus Lifesciences Limited
Route:INTRAVENOUS
Strength:20 mg in 1 mL
Approved: 2022/11/23
NDC:70771-1684

Singapore Approved Products

MYCAMINE POWDER FOR SOLUTION FOR INFUSION 50MG/VIAL
Manufacturer:Astellas Pharma Inc., PATHEON ITALIA S.P.A. (Bulk manufacturer/ Primary Packager)
Form:INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Strength:50 mg/vial
Online:Yes
Approved: 2013/12/18
Approval:SIN14464P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath